International Journal of Keratoconus and Ectatic Corneal Diseases

Register      Login

VOLUME 8 , ISSUE 2 ( July-December, 2019 ) > List of Articles


Therapeutic Analysis in Patients with Keratoconus

Natalia Carvalho, Thaiane F Guerra, Cristiane F Moutinho, Françuilner S dos Santos, Renan A Miyashiro, Rosangela A Simoncelli, Pablo F Rodrigues, Bernardo K Moscovici

Citation Information : Carvalho N, Guerra TF, Moutinho CF, dos Santos FS, Miyashiro RA, Simoncelli RA, Rodrigues PF, Moscovici BK. Therapeutic Analysis in Patients with Keratoconus. Int J Kerat Ect Cor Dis 2019; 8 (2):40-42.

DOI: 10.5005/jp-journals-10025-1184

License: CC BY-NC 4.0

Published Online: 01-02-2021

Copyright Statement:  Copyright © 2019; The Author(s).


Aim: This study aimed at assessing the therapeutic decisions made by an individual keratoconus specialist in the last 10 years, to treat patients with keratoconus. Materials and methods: We studied a case series and the descriptive analysis of individual cases treated by a single keratoconus specialist. Medical records of 636 patients totaling 1271 eyes were evaluated based on the therapeutic procedure used. Results: For the treatment of keratoconus, the specialist chose expectant (only spectacles) in 22.3% of the cases, contact lenses in 39.3%, implantation of intrastromal corneal ring segments (ICRS) in 27.7%, cross-linking in 0.9%, and penetrating keratoplasty in 8.5% of the cases. Conclusion: The keratoconus specialist preferred noninvasive therapeutic options to improve vision quality, such as spectacles and contact lenses. Clinical significance: Show the therapeutic preferences of a keratoconus specialist in order to compare with the daily practice.

  1. Global consensus on keratoconus and ectatic diseases. Cornea 2015 April;34(4):359–369. DOI: 10.1097/ICO.0000000000000408.
  2. Keratoconus: current perspectives. Clin Ophthalmol 2013:7:2019–2030. DOI: 10.2147/OPTH.S50119.
  3. Prevalence of keratoconus and subclinical keratoconus in subjects with astigmatism using pentacam derived parameters. J Ophthalmic Vis Res 2013;8(3):213–219.
  4. Characterization of corneal structure in keratoconus. J Cataract Refract Surg 2012;38(12):2167–2183. DOI: 10.1016/j.jcrs.2012.10.022.
  5. Collagen cross-linking: a new treatment paradigm in corneal disease – a review. Clin Exp Ophthalmol 2010;38(2):141–153. DOI: 10.1111/j.1442-9071.2010.02228.x.
  6. Riboflavin injection into the corneal channel for combined collagen crosslinking and intrastromal corneal ring segment implantation. J Cataract Refract Surg 2012;38(5):878–883. DOI: 10.1016/j.jcrs.2011.11.041.
  7. Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 2009;35(8):1358–1362. DOI: 10.1016/j.jcrs.2009.03.035.
  8. Anillo intracorneal. In: Albertazzi R, Centurion V. La moderna cirurgia refrativa. Buenos Aires: Gustavo Multedo; 1999. pp. 167–81.
  9. Modification of refraction by means of intracorneal inclusion. Int Ophthalmol Clin 1966;6(1):53–78. DOI: 10.1097/00004397-196600610-00004.
  10. Correction of ametropia with intracorneal lenses: an experimental study. Arch Ophthalmol 1964;72:541–547. DOI: 10.1001/archopht.1964.00970020541020.
  11. Intrastromalcorneal ring: 12-month sighted myopic eyes. J Refract Surg 1996;12(1):20–28. DOI: 10.3928/1081-597X-19960101-08.
  12. Effect of treatment sequence in combined intrastromal corneal rings and corneal collagen crosslinking for keratoconus. J Cataract Refract Surg 2009;35:2084–2091. DOI: 10.1016/j.jcrs.2009.07.008.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.